Stock DCTH DELCATH SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Delcath Systems, Inc.

Equities

DCTH

US24661P8077

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
5.71 USD -1.04% Intraday chart for Delcath Systems, Inc. +9.81% +37.26%
May. 06 Delcath Systems Says Phase 3 Data on Hepzato Kit Published in Oncology Journal MT
May. 06 Delcath Systems, Inc Announces Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT CI

Evolution of the average Target Price on Delcath Systems, Inc.

Price target over the last 5 years

History of analyst recommendation changes

090.QlNrlz7j_VKs2qmK_oaDtoh5MDfHelGFFVffVzcpZ3g.ChoNpge3lieV7e7DkavL37sMWFWlETzpcQGqGHpZKzUTChrGe7C8YeGzmQ~964b4044ffff92d3827c7690bc68c19e

Analyst Recommendations on Delcath Systems, Inc.

Delcath Systems Amends Supply, Manufacturing Agreement With Synerx Pharma, Mylan Teoranta for Melphalan Hydrochloride MT
HC Wainwright Adjusts Delcath Systems' Price Target to $20 From $18, Maintains Buy Rating MT
Canaccord Genuity Adjusts Delcath Systems Price Target to $21 From $18, Maintains Buy Rating MT
Roth MKM Adjusts Price Target on Delcath Systems to $13 From $10, Maintains Buy Rating MT
BTIG Adjusts Delcath Systems' Price Target to $20 From $19, Keeps Buy Rating MT
HC Wainwright Adjusts Price Target on Delcath Systems to $18 From $17, Maintains Buy Rating MT
Canaccord Genuity Adjusts Delcath Systems' Price Target to $18 From $14, Keeps Buy Rating MT
HC Wainwright Cuts Price Target on Delcath Systems to $17 From $19, Maintains Buy Rating MT
HC Wainwright Adjusts Delcath Systems' Price Target to $19 from $25, Keeps Buy Rating MT
BTIG Adjusts Delcath Systems' Price Target to $20 From $23, Reiterates Buy Rating MT
Canaccord Genuity Adjusts Delcath Systems' Price Target to $20 From $24, Reiterates Buy Rating MT
HC Wainwright Initiates Delcath Systems at Buy Rating With $25 Price Target MT
Delcath Says Hepzato Induces Statistically Significant Response Rates in Phase 3 Trial for Ocular Melanoma MT
DELCATH : Roth Capital Adjusts Delcath Systems' Price Target to $25 From $20, Maintains Buy Rating MT
DELCATH : Canaccord Genuity Initiates Coverage on Delcath Systems With Buy Rating, $24 Price Target MT
DELCATH : BTIG Starts Delcath Systems at Buy With $23 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.77 USD
Average target price
19.75 USD
Spread / Average Target
+242.29%
High Price Target
22 USD
Spread / Highest target
+281.28%
Low Price Target
16 USD
Spread / Lowest Target
+177.30%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Delcath Systems, Inc.

HC Wainwright
Canaccord Genuity
Roth MKM
BTIG
Roth Capital Partners

Ratings for Delcath Systems, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DCTH Stock
  4. Consensus Delcath Systems, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW